Abstract
AbstractBackgroundCombined obesity and Crohn's disease (CD) are becoming an increasing issue worldwide and in Saudi Arabia. In this series, we evaluate the feasibility and the outcomes of laparoscopic sleeve gastrectomy (LSG) in obese patients with CD.MethodsThis series is a retrospective analysis of our database with patients undergoing LSG from 2015 to 2020. Obese patients with CD were included.ResultsSixty‐one obese patients with CD underwent LSG with a mean preoperative body mass index (BMI) of 42.6 ± 4.3. The mean excess weight loss (% EWL) at 3, 6, 9 months, and 1 year was 41 ± 1.8, 51 ± 2.3, 67 ± 1.2, and 71 ± 3.1, respectively. There were no identified intra‐operative complications. The mean intra‐operative time was 40 ± 20. Only one patient developed a postoperative leak and was treated conservatively. No late postoperative complications were reported. During the follow‐up period, 6 (9.8%) patients were noted to have CD‐related medications discontinued (azathioprine and sulfasalazine), and 8 (13.1%) patients showed a reduction in the dosage of their medications.ConclusionLSG appears to be a safe and effective option for carefully selected patients with CD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
